The kinetics of crystalloid solutions in humans have not been adequately described previously. Therefore, we measured blood haemoglobin concentration during and for 120 min after i.v. infusion of 25 ml kg 
Expansion of the intravascular volume is an important property of crystalloid solutions given by i.v. infusion. The currently available methods used to describe this effect consist primarily of repeated measurement of blood volume by a radioactive isotope or dye. 1 2 For accurate results, these methods require an unchanged blood volume for 30-40 min during equilibration of the tracer, which makes them poorly suited for studies of non-steady-state conditions during fluid loading, hypotension and surgery. Changes in blood volume may also be indicated by haemodilution 3 4 but this approach has not been adopted widely.
The aim of this study was to describe the disposition of Ringer's solution in the body when infused at different rates using a new kinetic model. 5 We used dilution-time curves to estimate the size of the expandable space(s) into which the fluid is distributed. Pharmacokinetic principles adapted for fluid volumes were used to model the dynamic conditions during volume loading.
Subjects and methods
Ringer's acetate solution was given on a total of 30 occasions to six healthy female volunteers, aged 23-46 yr (mean 32 yr) and with a body weight of 50-75 kg (mean 60 kg). The study was approved by the local Ethics Committee and each volunteer gave informed consent.
Volunteers ate a light meal (consisting of one cup of coffee, tea or water and one sandwich) at home before going to hospital where the experiments were started at 08:00-10:00. No oral fluid or food was allowed between the morning meal and the end of the study. Volunteers voided, were immediately placed comfortably on a bed, and 20 min of equilibration was allowed before the infusions were started.
Cannulae were placed into the antecubital veins of both arms and Ringer's acetate solution (Pharmacia, Uppsala, Sweden; electrolyte content (mmol litre 91 ): Na 130, K 4, Ca 2, Mg 1, acetate 30 and Cl 110) was infused into one of these veins at a constant rate with the aid of one or several infusion pumps (IVAC 560, San Diego, CA, USA). Volunteers received, in random order and at intervals of at least 1 day, an i.v. infusion of Ringer's acetate 25 ml kg 91 over 15, 30, 45 and 80 min, and 12.5 ml kg 91 over 30 min.
MEASUREMENTS
Samples (3 ml) for measurement of blood haemoglobin (B-Hb) concentration using a Coulter Counter STKS (Counter Electronics, Hialeah, FL, USA) were obtained from the venous cannula not used for infusion before the infusion, every 10 min during infusion, and at 0, 5, 10, 15, 20, 25, 30, 60, 80, 100 and 120 min after infusion. After a blood sample was obtained, Ringer's solution 2 ml was injected to flush the cannula and a small discard sample was obtained before each blood sample to avoid undue haemodilution caused by this fluid. The first B-Hb sample in the series was obtained in duplicate and the mean was used in calculations.
In 25 experiments, urine volume was measured after blood had been collected at 30 and 120 min after the infusion had ended.
CALCULATIONS
Blood volume (BV) before treatment (BV 0 ) was calculated according to Nadler, Hidalgo and Bloch.
BV during treatment (BV n ) was estimated from dilution of B-Hb. The fraction of the infused Ringer's acetate solution that remained in blood (%) was calculated, without correction for blood sampling, from the quotient of BV change by the infused volume models, which are based on the assumption that the volume of the fluid space into which the fluid is distributed strives to be maintained in a way similar to one or two elastic balloons. The assumptions on which these kinetic models are based are summarized in figure 1 . The equations used for the calculations have been given previously. 5 Dilution of B-Hb concentration, with a correction made for loss of haemoglobin and fluid resulting from blood sampling, was used to indicate the water load in the VOFS models. As Ringer's solution essentially remains outside the erythrocytes, calculations were based on plasma volume, which was taken to be the product of (19packed cell volume) and estimated blood volume. During the experiment, packed cell volume was assumed to decrease in proportion to dilution of B-Hb, which is not unrealistic as the infused fluid is isotonic.
The one-fluid space model (VOFS1) uses nonlinear least-squares regression to calculate the baseline (target) volume of the expanded fluid space expanded by the infusion (V) and the elimination rate constant (k r ) and to predict fluid loss (sum of urine excretion and perspiration) during the experiment. Basal fluid loss (k b ) was set at 1.0 ml min 91 . The two-fluid space model (VOFS2) gives the target volumes of the central and peripheral fluid spaces expanded by the infusion (V 1 and V 2 ), rate constant for the diffusion of fluid between these fluid spaces (k t ), elimination rate constant (k r ) and fluid loss. A partial F test was applied to the residual errors (sum of squares) to select the best model for presentation. 7 The results are expressed as mean (95% confidence interval). The standard error of the mean (SEM) was used when the data were based on only six experiments. The statistical evaluation also comprised one-way and two-way analyses of variance (ANOVA), repeated-measures ANOVA followed by the Scheffé test, and simple linear regression analysis. P:0.05 was considered significant.
Results
The highest infusion rate (25 ml kg 91 over 15 min) was associated with mild symptoms in all volunteers. Subjects reported a sense of swelling in the hands or face (n:3), an abdominal lump (n:2), slight dyspnoea (n:3), headache (n:1) and analgesia around the lips (n:1). Occasional complaints of "feeling swollen" were noted during a few other experiments, but these symptoms were very mild.
The fraction of fluid given that remained in blood was higher than the expected 20% during all infusions and for the first 30 min thereafter. Ringer's solution was a more effective plasma expander when it was infused slowly ( fig. 2 ). Blood volume increased by a maximum of 550 ml regardless of how fast the solution was infused ( fig. 3) .
The dilution-time curves were then analysed according to the one-and two-fluid space models, VOFS1 and VOFS2 (figs 1, 3). Only 10 of the 30 dilution-time curves were more adequately described by VOFS2 (table 1) .
When using the most appropriate model for each experiment, two-way ANOVA showed that the size Figure 1 Schematic diagram of the VOFS1 (upper) and VOFS2 (lower) models. Fluid is infused at a constant rate (k i ) and enters a space having the volume (v) which changes as a result of fluid leaving the space at a basal rate (k b ) and at a controlled rate (k r ) proportional to the deviation from the target value (V). In VOFS2, a secondary fluid space of volume (v 2 ) which exchanges fluid with the primary fluid space (v 1 ) and the rate of volume equlibration between them is proportional to the difference in the relative deviation from the target value by a constant (k t ). of the expanded body fluid space (V or V 1; V 2 ) was associated both with the infusion regimen (P:0.01) and the subject (P:0.02; interaction effect P:0.04). These significance levels became stronger when V or V 1; V 2 was divided by body weight.
When mean values for each infusion rate were compared, however, it appeared that 12.5 ml kg interval 3.8-5.8 litre)) while it was almost twice as large when 25 ml kg 91 was given over 15 min (P:0.05 by repeated-measures ANOVA) (table 1).
In the 10 experiments in which VOFS2 was optimal, V 1 was 2.6 (1.9-3.4) litre and V 2 amounted to 6.4 (3.8-9.1) litre. The total expandable volume was significantly larger compared with experiments in which the one-fluid space model was sufficient (table 2). The value of the elimination rate constant k r differed significantly between subjects (ANOVA P:0.01) but not between infusion rates (table 3) . For the entire series of experiments, the mean value of k r was 95 (68-122) ml min
91
. Data on urine volume were consistent with results of volume kinetic analysis. Hence, the measured urine volume correlated with the calculated k r (fig.  4 ). In the experiments where VOFS2 was optimal, not only k r and predicted fluid loss, but also urine volume were low (table 2) . Some volunteers, notably those who often handled the fluid load according to VOFS1, voided more promptly than others (table 3) . 
Discussion
The initial data analysis showed results that differ from the accepted view of how the body handles Ringer's acetate solution. During volume loading, a much greater fraction of the infused fluid was retained in the blood than the 20-25% commonly indicated in medical textbooks. In fact, 20% was not attained until 30 min after infusion, and some of this dilution might have been caused by blood sampling. The percentage of infused fluid that remained in blood was also dependent on the infusion rate. This finding can be understood better by expressing haemodilution as a change in blood volume, where it becomes apparent that the load-volume relationship should be described by an exponential function rather than by a straight line. The steady-state level corresponded to expansion of blood volume by approximately 550 ml in our resting healthy females. This finding is of interest when Ringer's solution is given very rapidly, such as when volume loading is performed before induction of spinal or extradural anaesthesia. As the volume effect of Ringer's solution is the main purpose of the load, it would seem advisable to slow down an i.v. infusion given very rapidly when steady state is approached. To continue the infusion at a high rate confers no benefit.
These observations suggest that the disposition of a volume load given by i.v. infusion is usually described in oversimplified terms. A mathematical model is needed to analyse more accurately and simulate what happens to the fluid under different conditions. The model used here was developed to describe a dynamic situation. The molecules used to estimate the dilution are already present in the circulation and no radioactive tracer is needed. It is assumed that powerful homeostatic forces act to restore any deviation of fluid spaces to an optimal "target volume" by means of dilution-dependent elimination of fluid. The validity of this view is supported by this study, as elimination of fluid predicted by the model correlated well with urine volume measured.
One-and two-fluid space models were applied to the data. Evidence of expansion of both central and peripheral fluid spaces was found primarily in experiments where a relatively small fraction of the infused volume (mean 48%) was passed during the 2-h follow-up period. In these cases, the volume of the central fluid space was very close to the estimated plasma volume. In most experiments, however, the two-fluid space model offered marginal improvement of the residual error resulting from the curvefitting procedure. This implies that Ringer's solution, from a kinetic point of view, usually diluted a single well-stirred fluid space. In these experiments, we found more prompt renal excretion of the infused fluid (mean 75%) than in experiments where the two-volume model significantly decreased the residual error. The fact that experiments where the fluid was handled according to VOFS1 were accompanied by both a larger model-predicted fluid loss and a larger urine volume than VOFS2 supports our view that our fluid space models have a physiological basis.
The current view of the disposition of crystalloid solutions such as Ringer's solution is that they are distributed throughout the whole extracellular volume space, which is approximately 12 litre in adult females. However, this study showed that dilution of blood reflected an expandable volume of only 5 litre. This is compatible with the view that Ringer's solution is sequestered in the entire extracellular fluid space while expanding only 40% of it. This finding can probably be explained by a lower compliance for volume expansion in some tissue regions. In fact, the interstitial fluid space is often conceived as a two-phase gel 8 ; one phase is difficult to expand because it has a high density of collagen, elastin and glycosaminoglycan, the other phase expands more easily because the density of these macromolecules is lower.
Our results showed that the kinetic model is suitable for further development, as similar results were obtained when the fluid was infused at different rates and also when a different dose was given. The fastest administration of Ringer's solution was the only exception. The large target volume and the symptoms associated with the highest infusion rate probably reflect the fact that areas with lower compliance for accumulation of fluid were also expanded.
To the anaesthetist, the expandable (target) volume is a useful concept as the dilution of the expandable fluid space indicates how much fluid remains in the body during and after i.v. infusion. The volume of the extracellular fluid should apparently not be used for such estimations. Similarly, the rate of urine excretion is the product of k r and plasma dilution, although we also have to consider a small basal diuresis.
